Clinical Trial

Efficacy and Safety in the Combination of Ibuprofen / Loratadine Versus Ibuprofen Versus Loratadine

Unknown Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated August 2, 2024 (before its estimated January 20, 2025 completion). Its status may not reflect the trial's current state.
Summary
Phase III longitudinal, multicenter, randomized, double-blind clinical trial. The aim of this study is to evaluate the efficacy and safety of the drug combination of Ibuprofen/Loratadine versus Ibuprofen versus Loratadine as monotherapy for the symptomatic treatment of the common cold.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06531707
Lead Sponsor Laboratorios Silanes S.A. de C.V.
Conditions Common Cold
Enrollment 177 participants
Start Date 2024-05-20
Primary Completion 2025-01-20 (estimated)
Study Completion 2025-02-20 (estimated)
Updated on ClinicalTrials.gov 2024-08-02